patient weight News
-
Randomized Controlled Trial Examining the Ripple Effect of a Nationally Available Weight Management Program on Untreated Spouses
Researchers have found that when one member of a couple commits to losing weight, the chances are good their partner will lose weight too, even if they are not actively participating in a weight loss intervention. The study followed 130 couples—defined as partners living together—for six months, during which one person in each relationship followed a weight loss program. The couples ...
-
The Additional Costs and Health Effects of a Patient Having Overweight or Obesity: A Computational Model
A new study published by The Obesity Society finds that being overweight can lead to financial costs. This is largely due to the need for more medical costs and loss of productivity caused by obesity. The research suggests that a 20-year-old who goes from being obese (BMI of 30 or higher) to overweight (BMI of 25 to 29.9) would save an average of $17,655 in direct medical costs and productivity ...
-
Potrero Medical Announces Launch of New Furosemide Stress Test App
Potrero Medical, innovator of the Accuryn Monitoring System, announced the launch of its newest software App for the Accuryn™ Monitor and AccuTab™. The Accuryn Monitoring System includes a revolutionary sensor-integrated foley catheter that provides real-time, actionable information to healthcare providers, enabling them to take important, earlier steps to prevent disease state ...
-
Adiposs receives endorsement to proceed to Clinical Trials
We are thrilled to announce that following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK, Adiposs received endorsement for its flagship product, ImageBAT, to proceed to Clinical Trials. ImageBAT is the state-of-the-art imaging product that makes brown adipose tissue visible with a fast and pain-free CT scan. It enables early detection ...
By Adiposs
-
Camurus announces dosing initiated in Phase 3 trial of weekly setmelanotide in patients with genetic obesity disorder
Camurus (NASDAQ STO: CAMX) today announces that the company’s license partner Rhythm Pharmaceuticals has dosed the first patients in a Phase 3 trial evaluating weekly setmelanotide subcutaneous depot in patients six years of age and older with a rare genetic disease of obesity. “We are pleased with the progress of our collaboration with Rhythm and today’s announcement of the ...
By Camurus AB
-
Adiposs raises CHF 1.8M Pre-Series a Funding led by Privilège Ventures to start Clinical Trials and Product Industrialization
GENEVA, SWITZERLAND – DECEMBER 24, 2021 – Adiposs SA, the developer of a unique diagnostic product for the non-invasive early detection of body wasting-cachexia, announced a CHF 1.8M first closing of its Pre-Series A round. The round was led by Privilège Ventures, a Swiss-based venture capital firm focused on seed and early-stage investments. Other investors include ...
By Adiposs
-
ReShape Integrated Dual Balloon System to Fill Significant Gap in Obesity Treatment Spectrum
ReShape Medical today announced that the Company has submitted a Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the ReShape Integrated Dual Balloon System, the first and only dual balloon for non-surgical weight loss designed for people with a 30-40 body mass index (BMI). The ReShape Integrated Dual Balloon System is the first device to meet its primary ...
-
ReShape Lifesciences Announces 2017 Weight Loss Contest Winner
ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced the winners of its 2017 weight loss contest, which recognizes patients for their successful weight loss with the ReShape Balloon™. The contest winner lost a total of 80 pounds, or 41% total weight loss (TWL), with 60 pounds, or 28% TWL, lost ...
-
FONAR Subsidiary, HMCA, Expands with Acquisition in Yonkers, New York
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, announced today that it has acquired a Stand-Up MRI facility in Yonkers, New York, from where its diagnostic imaging management subsidiary, Health Management Company of America (HMCA) will provide non-medical management services for Comprehensive MRI of New York, P.C. Tim Damadian, president and CEO of FONAR Corporation, said, ...
-
FONAR Set to Join Russell 3000 and 2000 Indexes
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, reported today that upon the opening of U.S. markets on June 29, 2020, FONAR will, as part of the annual reconstitution of the Russell Indexes, be joining the broad-market Russell 3000 Index and the Russell 2000 Index. The Russell 3000 Index is a market-capitalization-weighted equity index that tracks the performance of the 3,000 ...
-
ReShape Medical, Inc. Completes $38 Million Series D Financing
ReShape Medical® today announced that it has completed a Series D financing of $38 million led by HealthCor Partners Management, L.P. with participation from Endeavour Vision SA and existing investors, SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners and Venture Investors. The announcement follows the recent approval of the ReShape™ Integrated Dual Balloon System, a ...
-
`It was a life saver`: New London developed device for feeding tube insertions is a world first
Researchers in London, Ont., are the first in the world to use a new device for feeding tube insertion that can improve patient safety and reduce the cost of health-care services. A team from Lawson Health Research Institute has partnered with CoapTech LLC, a medical device company, to study the use of the PUMA-G System. In October of last year, the medical and research teams were the first in ...
By CoapTech
-
FONAR Celebrates the 50th Anniversary of the Origination of the MRI
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, celebrated a special anniversary on September 17, 2019: It was 50 years ago that Raymond V. Damadian, M.D., founder and chairman of FONAR Corporation, first thought about developing a device using magnetic resonance to scan the human body to detect cancer. On September 17, 1969, Dr. Damadian sent a letter to Dr. George Mirick ...
-
Biotricity wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled real-time monitoring and predictive analytics for stroke due to chronic kidney failure
Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company, today announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity’s innovative artificial intelligence-driven (‘AI’) system of real-time monitoring and prediction technology, in subjects with ...
-
ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer
ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board of Directors has appointed Paul F. Hickey as President and Chief Executive Officer and as a member of the Board of Directors, effective August 15, 2022. Mr. Hickey succeeds Bart Bandy, who has separated from the company to pursue other ...
-
Fonar Board of Directors Appoints Independent Director
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning, today announced that on November 17, 2021, its board of directors appointed John Collins as a replacement independent director to a vacancy on the Company´s board of directors and audit committee. Timothy Damadian, president and CEO of FONAR, said, “Our primary source of income and growth is attributable to FONAR’s ...
-
Emovi, Inc. Announces Partnership with Sports Illustrated as Key Sponsor for The Sports Illustrated Awards
Emovi, Inc., a global medical device developer, today announced a partnership with Sports Illustrated as a sponsor of the 2020 Sports Illustrated Awards (SI Awards) The SI Awards will take place in Las Vegas on December 19. Viewers can stream the primetime broadcast live via the Sports Illustrated Facebook page beginning at 7:00 PM ET . The award ceremony will feature special presentations, ...
By Emovi
-
ReShape Lifesciences Receives FDA 510(k) Clearance for the GIBI HD Calibration Tubes for use in Gastric and Bariatric Procedures
New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric Banding Company to Introduce Product at IFSO 2022 World Congress in August; Sales to Commence in September ReShape Lifesciences (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced ...
-
Kinestique Diagnostic Centre Integrates New Technology that Accurately and Objectively Addresses Knee Pain, The First in Singapore, Asia
Kinestique Diagnostic Centre announces today the launch of the KneeKGTM in their inaugural clinic, the firsts in the country and Southeast Asia. Developed by Emovi, the KneeKGTM is to the knee, what an EKG is for the heart, and provides valuable data that enables physicians and other healthcare professionals to determine the most appropriate patient-specific care plan to restore optimal knee ...
By Emovi
-
Intecore Physical Therapy the First and ONLY PT Clinic in the Western US to Integrate KneeKG into Clinics
Outpatient orthopedic and sports medicine rehabilitation provider, Intecore Physical Therapy, broadens its care and support for patients experiencing knee pain with the addition of the KneeKG™ System into all of their clinics. Developed by Emovi, the KneeKG™ is used on the knee, like an EKG is for the heart, by providing valuable data that enables the Physical Therapy team to ...
By Emovi
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you